Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home

Background: Older patients from nursing homes are commonly exposed to polypharmacy before a hospital admission. Deprescribing has been promoted as a solution to this problem, though systematic reviews have not found benefit. The aim of this study was to understand if in-hospital deprescribing of cer...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Patrick Russell, Udul Hewage, Cameron McDonald, Campbell Thompson, Richard Woodman, Arduino A. Mangoni
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d302134b94ad4190b4d67618ba8d5f5f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d302134b94ad4190b4d67618ba8d5f5f
record_format	dspace
institution	DOAJ
collection	DOAJ
language	EN
topic	Therapeutics. Pharmacology RM1-950
spellingShingle	Therapeutics. Pharmacology RM1-950 Patrick Russell Udul Hewage Cameron McDonald Campbell Thompson Richard Woodman Arduino A. Mangoni Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
description	Background: Older patients from nursing homes are commonly exposed to polypharmacy before a hospital admission. Deprescribing has been promoted as a solution to this problem, though systematic reviews have not found benefit. The aim of this study was to understand if in-hospital deprescribing of certain classes of medications is associated with certain benefits or risks. Methods: We conducted a prospective, multicentre, cohort study in 239 medical inpatients ⩾75 years (mean age 87.4 years) who were exposed to polypharmacy (⩾5 medications) prior to admission and discharged to a nursing home for permanent placement. Patients were categorised by whether deprescribing occurred, mortality and readmissions were assessed 30 and 90 days after hospital discharge. The EQ-5D-5 L health survey assessed changes in health-related quality of life (HRQOL) at 90 days, with comparison to EQ-5D-5 L results at day 30. Latent class analysis (LCA) was used to investigate associations between patterns of prescribed and deprescribed medications and mortality. Results: Patients for whom deprescribing occurred had a higher Charlson Index; there were no differences between the groups in principal diagnosis, total or Beers list number of medications on admission. The number of Beers list medications increased in both groups before discharge. Patients who had medications deprescribed had nonsignificantly greater odds of dying within 90 days [odds ration (OR) = 3.23 (95% confidence interval (CI): 0.68, 14.92; p = 0.136]. Deprescribing of certain classes was associated with higher 90-day mortality: antihypertensives (OR = 2.27, 95% CI: 1.004, 5; p = 0.049) and statins (OR = 5, 95% CI: 1.61, 14.28; p = 0.005). Readmissions and 1-year mortality rates were similar. There was no deterioration in HRQOL when medications were deprescribed. LCA showed that patients with the least medication changes had the lowest mortality. Conclusion: Deprescribing certain classes of medications during hospitalisation was associated with worse mortality, but not readmissions or overall HRQOL. Larger controlled deprescribing studies targeting specific medications are warranted to further investigate these findings. This study was registered with the Australian and New Zealand Clinical Trials Registry, ACTRN1 2616001336471. Plain language summary Background: When an older person living in a nursing home is admitted to hospital, does stopping long-term medications help them? Many older people from nursing homes take a large number of medications each day to treat symptoms and prevent adverse events. “Polypharmacy” is a term used to describe taking multiple long-term medications, and it is associated with many negative outcomes such as increased number of falls, cognitive decline, hospital readmission, even death. Deprescribing of nonessential medications – whether stopping or reducing the dose – is promoted as good hospital practice and is assumed to help older frail people live longer and feel better. However, we often don’t fully understand what is and is not essential. We wanted to better understand the effect of deprescribing long-term medications for older frail patients during an unplanned hospital admission as they were going to a nursing home to live. Methods: While admitted to hospital, medications are often reviewed by a clinical pharmacist and specialist physician. Sometimes medications are ceased; sometimes they are not. This gave us the opportunity to study two groups of older frail people from nursing homes: those who had regular, long-term medications ceased or reduced and those who did not. We wanted to see if one group did better. For example, did they feel worse if we stopped certain medications? Did they suffer other bad events compared with those patients for whom no medications were ceased? Were they readmitted to hospital earlier or more often? Results and conclusion: Despite the assumption that stopping medications for this type of patient is good practice, we found no benefit. We were also surprised to find stopping or reducing certain drug classes (e.g. antihypertensives and cholesterol-lowering drugs) was associated with greater mortality. Larger, randomised studies will better answer these important questions.
format	article
author	Patrick Russell Udul Hewage Cameron McDonald Campbell Thompson Richard Woodman Arduino A. Mangoni
author_facet	Patrick Russell Udul Hewage Cameron McDonald Campbell Thompson Richard Woodman Arduino A. Mangoni
author_sort	Patrick Russell
title	Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
title_short	Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
title_full	Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
title_fullStr	Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
title_full_unstemmed	Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
title_sort	prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/d302134b94ad4190b4d67618ba8d5f5f
work_keys_str_mv	AT patrickrussell prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome AT udulhewage prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome AT cameronmcdonald prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome AT campbellthompson prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome AT richardwoodman prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome AT arduinoamangoni prospectivecohortstudyofnonspecificdeprescribinginoldermedicalinpatientsbeingdischargedtoanursinghome
_version_	1718430583260971008
spelling	oai:doaj.org-article:d302134b94ad4190b4d67618ba8d5f5f2021-11-12T12:03:19ZProspective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home2042-099410.1177/20420986211052344https://doaj.org/article/d302134b94ad4190b4d67618ba8d5f5f2021-10-01T00:00:00Zhttps://doi.org/10.1177/20420986211052344https://doaj.org/toc/2042-0994Background: Older patients from nursing homes are commonly exposed to polypharmacy before a hospital admission. Deprescribing has been promoted as a solution to this problem, though systematic reviews have not found benefit. The aim of this study was to understand if in-hospital deprescribing of certain classes of medications is associated with certain benefits or risks. Methods: We conducted a prospective, multicentre, cohort study in 239 medical inpatients ⩾75 years (mean age 87.4 years) who were exposed to polypharmacy (⩾5 medications) prior to admission and discharged to a nursing home for permanent placement. Patients were categorised by whether deprescribing occurred, mortality and readmissions were assessed 30 and 90 days after hospital discharge. The EQ-5D-5 L health survey assessed changes in health-related quality of life (HRQOL) at 90 days, with comparison to EQ-5D-5 L results at day 30. Latent class analysis (LCA) was used to investigate associations between patterns of prescribed and deprescribed medications and mortality. Results: Patients for whom deprescribing occurred had a higher Charlson Index; there were no differences between the groups in principal diagnosis, total or Beers list number of medications on admission. The number of Beers list medications increased in both groups before discharge. Patients who had medications deprescribed had nonsignificantly greater odds of dying within 90 days [odds ration (OR) = 3.23 (95% confidence interval (CI): 0.68, 14.92; p = 0.136]. Deprescribing of certain classes was associated with higher 90-day mortality: antihypertensives (OR = 2.27, 95% CI: 1.004, 5; p = 0.049) and statins (OR = 5, 95% CI: 1.61, 14.28; p = 0.005). Readmissions and 1-year mortality rates were similar. There was no deterioration in HRQOL when medications were deprescribed. LCA showed that patients with the least medication changes had the lowest mortality. Conclusion: Deprescribing certain classes of medications during hospitalisation was associated with worse mortality, but not readmissions or overall HRQOL. Larger controlled deprescribing studies targeting specific medications are warranted to further investigate these findings. This study was registered with the Australian and New Zealand Clinical Trials Registry, ACTRN1 2616001336471. Plain language summary Background: When an older person living in a nursing home is admitted to hospital, does stopping long-term medications help them? Many older people from nursing homes take a large number of medications each day to treat symptoms and prevent adverse events. “Polypharmacy” is a term used to describe taking multiple long-term medications, and it is associated with many negative outcomes such as increased number of falls, cognitive decline, hospital readmission, even death. Deprescribing of nonessential medications – whether stopping or reducing the dose – is promoted as good hospital practice and is assumed to help older frail people live longer and feel better. However, we often don’t fully understand what is and is not essential. We wanted to better understand the effect of deprescribing long-term medications for older frail patients during an unplanned hospital admission as they were going to a nursing home to live. Methods: While admitted to hospital, medications are often reviewed by a clinical pharmacist and specialist physician. Sometimes medications are ceased; sometimes they are not. This gave us the opportunity to study two groups of older frail people from nursing homes: those who had regular, long-term medications ceased or reduced and those who did not. We wanted to see if one group did better. For example, did they feel worse if we stopped certain medications? Did they suffer other bad events compared with those patients for whom no medications were ceased? Were they readmitted to hospital earlier or more often? Results and conclusion: Despite the assumption that stopping medications for this type of patient is good practice, we found no benefit. We were also surprised to find stopping or reducing certain drug classes (e.g. antihypertensives and cholesterol-lowering drugs) was associated with greater mortality. Larger, randomised studies will better answer these important questions.Patrick RussellUdul HewageCameron McDonaldCampbell ThompsonRichard WoodmanArduino A. MangoniSAGE PublishingarticleTherapeutics. PharmacologyRM1-950ENTherapeutic Advances in Drug Safety, Vol 12 (2021)

Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home

Ejemplares similares